Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial
Completed
- Conditions
- Childhood Infratentorial EpendymomaChildhood Supratentorial EpendymomaNewly Diagnosed Childhood Ependymoma
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 80
- Registration Number
- NCT01407744
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Completed
- Conditions
- Leukemia
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1000
- Registration Number
- NCT01407757
Cell Samples From Patients With Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2011-07-15
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01395628
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 300
- Registration Number
- NCT01387724
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
Completed
- Conditions
- Localized OsteosarcomaOsteoblastic OsteosarcomaRecurrent OsteosarcomaMetastatic Osteosarcoma
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01374672
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase 3
Completed
- Conditions
- Acute Leukemias of Ambiguous LineageBacterial InfectionDiarrheaFungal InfectionMusculoskeletal ComplicationsNeutropeniaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaUntreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 624
- Registration Number
- NCT01371656
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Southern California Permanente Medical Group, Downey, California, United States
🇺🇸City of Hope Medical Center, Duarte, California, United States
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 40
- Registration Number
- NCT01365949
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 7
- Registration Number
- NCT01366170
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT01365962
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 23
- Registration Number
- NCT01366157